PT  - JOURNAL ARTICLE
AU  - M. Ozguroglu
AU  - O. Sari
AU  - H. Turna
TI  - Devastating effects of chemotherapy: deafness and acute renal failure in a patient with epithelial ovarian cancer
AID  - 10.1136/ijgc-00009577-200602001-00072
DP  - 2006 Jan 01
TA  - International Journal of Gynecologic Cancer
PG  - 394--396
VI  - 16
IP  - Suppl 1
4099  - http://ijgc.bmj.com/content/16/Suppl_1/394.short
4100  - http://ijgc.bmj.com/content/16/Suppl_1/394.full
SO  - Int J Gynecol Cancer2006 Jan 01; 16
AB  - Paclitaxel and platinum combination is the standard chemotherapy regimen for patients with advanced epithelial ovarian cancer. The dose-limiting toxicity effects of this combination are myelosuppression and neuropathy. Herein, we report a case of a 71-year-old female with advanced epithelial ovarian cancer who developed bilateral total loss of hearing and acute renal failure related with paclitaxel- and carboplatin-based chemotherapy. Acute renal failure accompanied by complete loss of hearing in patients treated with carboplatin and paclitaxel combination has not been previously reported. This uncommon adverse effect of carboplatin and paclitaxel combination was discussed, and all the literature in English related with the toxicity of paclitaxel and carboplatin were reviewed.